Acknowledgement
The study was financially supported by the National Natural Science Foundation of China (Nos. 81873025, 82003970) and Jiangsu Provincial Natural Science Foundation of China (BK20181423).
References
- Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 2014 Nov;10(11):634-42. https://doi.org/10.1038/nrneurol.2014.181
- Andrade C, Radhakrishnan R. The prevention and treatment of cognitive decline and dementia: an overview of recent research on experimental treatments. Indian J Psychiatr 2009 Jan;51(1):12-25. https://doi.org/10.4103/0019-5545.44900
- Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 2006 Nov-Dec;25(6):265-71.
- Jongsiriyanyong S, Limpawattana P. Mild cognitive impairment in clinical practice: a review article. Am J Alzheimers Dis Other Demen 2018 Dec;33(8): 500-7. https://doi.org/10.1177/1533317518791401
- Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia 2000 Mar;15(3):93-101.
- Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 2000 Aug;71(Suppl 1):S1-5. https://doi.org/10.1016/S0367-326X(00)00170-2
- Smith I, Williamson EM, Putnam S, Farrimond J, Whalley BJ. Effects and mechanisms of ginseng and ginsenosides on cognition. Nutr Rev 2014 May;72(5):319-33. https://doi.org/10.1111/nure.12099
- Mook-Jung I, Hong HS, Boo JH, Lee KH, Yun SH, Cheong MY, et al. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. J Neurosci Res 2001 Mar 15;63(6):509-15. https://doi.org/10.1002/jnr.1045
- DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002 Feb;51(2):145-55. https://doi.org/10.1002/ana.10069
- Ye R, Han J, Kong X, Zhao L, Cao R, Rao Z, et al. Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol Pharm Bull 2008 Oct;31(10): 1923-7. https://doi.org/10.1248/bpb.31.1923
- Zhang G, Liu A, Zhou Y, San X, Jin T, Jin Y. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol 2008 Feb 12;115(3):441-8. https://doi.org/10.1016/j.jep.2007.10.026
- Zhao HF, Li Q, Li Y. Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and upregulating the plasticity-related proteins in hippocampus. Neuroscience 2011 Jun 2;183:189-202. https://doi.org/10.1016/j.neuroscience.2011.03.048
- Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci U S A 2009 Dec 22;106(51):21984-9. https://doi.org/10.1073/pnas.0910040106
- Zhao YN, Wang ZL, Dai JG, Chen L, Huang YF. Preparation and quality assessment of high-purity ginseng total saponins by ion exchange resin combined with macroporous adsorption resin separation. Chin J Nat Med 2014 May;12(5):382-92.
- Ouyang LF, Wang ZL, Dai JG, Chen L, Zhao YN. Determination of total ginsenosides in ginseng extracts using charged aerosol detection with post-column compensation of the gradient. Chin J Nat Med 2014 Nov;12(11):857-68.
- Pai MY, Lomenick B, Hwang H, Schiestl R, McBride W, Loo JA, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol 2015;1263:287-98. https://doi.org/10.1007/978-1-4939-2269-7_22
- Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: integrating information about genes, proteins and diseases. Trends Genet 1997 Apr;13(4):163. https://doi.org/10.1016/S0168-9525(97)01103-7
- Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res 2015 Jan;43(Database issue): D789-98. https://doi.org/10.1093/nar/gku1205
- Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 2017 Jan 4;45(D1): D362-8.
- Lomenick B, Jung G, Wohlschlegel JA, Huang J. Target identification using drug affinity responsive target stability (DARTS). Curr Protoc Chem Biol 2011 Dec 1;3(4):163-80. https://doi.org/10.1002/9780470559277.ch110180
- Chang J, Kim Y, Kwon HJ. Advances in identification and validation of protein targets of natural products without chemical modification. Nat Prod Rep 2016 May 4;33(5):719-30. https://doi.org/10.1039/C5NP00107B
- Sun J, Prabhu N, Tang J, Yang F, Jia L, Guo J, et al. Recent advances in proteomewide label-free target deconvolution for bioactive small molecules. Med Res Rev 2021 Feb 3;41(6):2893-926. https://doi.org/10.1002/med.21788
- Sengupta B, Stemmler M, Laughlin SB, Niven JE. Action potential energy efficiency varies among neuron types in vertebrates and invertebrates. PLoS Comput Biol 2010 Jul 1;6:e1000840.
- Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006 Oct 19;443(7113):787-95. https://doi.org/10.1038/nature05292
- Pollard AK, Craig EL, Chakrabarti L. Mitochondrial complex 1 activity measured by spectrophotometry is reduced across all brain regions in ageing and more specifically in neurodegeneration. PLoS One 2016;11(6):e0157405. https://doi.org/10.1371/journal.pone.0157405
- Peralta S, Torraco A, Wenz T, Garcia S, Diaz F, Moraes CT. Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage. Hum Mol Genet 2014 Mar 15;23(6):1399-412. https://doi.org/10.1093/hmg/ddt526
- Huang T, Fang F, Chen L, Zhu Y, Zhang J, Chen X, et al. Ginsenoside Rg1 attenuates oligomeric Abeta(1-42)-induced mitochondrial dysfunction. Curr Alzheimer Res 2012 Mar;9(3):388-95. https://doi.org/10.2174/156720512800107636
- Sun M, Huang C, Wang C, Zheng J, Zhang P, Xu Y, et al. Ginsenoside Rg3 improves cardiac mitochondrial population quality: mimetic exercise training. Biochem Biophys Res Commun 2013 Nov 8;441(1):169-74. https://doi.org/10.1016/j.bbrc.2013.10.039
- Zhou JS, Wang JF, He BR, Cui YS, Fang XY, Ni JL, et al. Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome C release in isolated spinal cord mitochondria: involvement of kinase-mediated pathways. Int J Mol Sci 2014 Jun 3;15(6):9859-77. https://doi.org/10.3390/ijms15069859
- Gonzalez-Burgos E, Fernandez-Moriano C, Lozano R, Iglesias I, GomezSerranillos MP. Ginsenosides Rd and Re co-treatments improve rotenoneinduced oxidative stress and mitochondrial impairment in SH-SY5Y neuroblastoma cells. Food Chem Toxicol 2017 Nov;109(Pt 1):38-47. https://doi.org/10.1016/j.fct.2017.08.013
- Yang LX, Zhang X, Zhao G. Ginsenoside Rd attenuates DNA damage by increasing expression of DNA glycosylase endonuclease VIII-like proteins after focal cerebral ischemia. Chin Med J (Engl) 2016 Aug 20;129(16):1955-62. https://doi.org/10.4103/0366-6999.187851
- Ye R, Kong X, Yang Q, Zhang Y, Han J, Zhao G. Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice. Neuropharmacology 2011 Sep;61(4):815-24. https://doi.org/10.1016/j.neuropharm.2011.05.029